Researchers are exploring the use of molecular glues to target proteins that were previously considered undruggable. This approach has the potential to lead to new cancer treatments and other therapies, with some companies already raising funds to develop related technologies. The field is advancing with the help of technological advances, including high-throughput proteomics and artificial intelligence.